Fertility Services Market Report 2026

The fertility services market size has grown rapidly in recent years. It will grow from $73.96 billion in 2025 to $84.23 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to delayed parenthood trends, increasing infertility prevalence, expansion of ivf clinics, improved reproductive diagnostics, rising social acceptance of fertility treatments.

The fertility services market size is expected to see rapid growth in the next few years. It will grow to $139.79 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to advancements in assisted reproduction technologies, growth in fertility tourism, increasing use of ai in fertility planning, expansion of fertility preservation services, rising investment in reproductive healthcare. Major trends in the forecast period include rising demand for assisted reproductive technologies, expansion of fertility clinics and centers, growing use of personalized fertility treatment plans, increased cross-border fertility tourism, integration of digital tools in fertility counseling.

The increasing prevalence of PCOS (Polycystic Ovarian Syndrome) is expected to drive the growth of the fertility services market in the coming years. Polycystic Ovary Syndrome is a widespread hormonal condition that affects individuals with ovaries, most commonly during their reproductive years. As the incidence of PCOS continues to rise, the demand for fertility services such as in vitro fertilization (IVF) and other assisted reproductive technologies is likely to grow, thereby supporting expansion of the fertility services market. For example, in June 2023, the World Health Organization, a Switzerland-based intergovernmental organization, reported that approximately 8-13% of women of reproductive age are estimated to be affected by PCOS, with up to 70% of cases remaining undiagnosed worldwide. Therefore, the growing prevalence of PCOS is fueling the growth of the fertility services market.

Leading companies in the fertility services market are increasingly focusing on the development of advanced technologies, such as AI-enabled embryo selection algorithms, to strengthen their competitive positioning. AI-enabled embryo selection uses advanced machine learning techniques applied to time-lapse imaging and morphological data to predict embryo implantation potential, thereby improving IVF success rates. For instance, in August 2025, Nova IVF Fertility, a UK-based fertility services provider, launched Vita Embryo, an AI-driven embryo assessment solution. This technology delivers accurate embryo viability rankings, reduces IVF cycle duration, and enhances treatment transparency. It is designed to improve pregnancy success rates, lower the risk of multiple pregnancies, and boost clinical efficiency. While these innovations enhance precision and patient care, their adoption also requires addressing challenges related to higher costs, regulatory compliance, and algorithm transparency. Such technological advancements are expected to significantly transform the fertility services market by increasing treatment success and improving patient experiences globally.

In November 2023, IVI RMA, a Spain-based assisted reproductive technology (ART) company, acquired the North American operations of Eugin Group. This strategic acquisition strengthens IVI RMA’s market leadership in North America and reinforces its commitment to delivering evidence-based fertility solutions with the highest likelihood of success to a broad patient population. Eugin Group is a Spain-based fertility services provider.

Major companies operating in the fertility services market are Vitrolife, Merck KGaA, Progyny Inc., Virtus Health, Medicover Group, Apollo Hospitals Enterprise Ltd., Integramed America, Inc., The Johns Hopkins Health System Corp, Care Fertility, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bloom Fertility Center, Center for Advanced Reproductive Medicine and Infertility, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, IHH Healthcare Berhad, IVF NAMBA Clinic, IVF Sri Lanka Life Plus (Pvt) Ltd, KL Fertility & Gynecology Centre, LIFE - Lahore Institute of Fertility & Endocrinology, Maria Fertility Hospital, Morula IVF, Nepal International Fertility Centre, Repromed, SAFE Fertility Center, Southend Fertility and IVF, Thomson Medical Pte Ltd, TMC Fertility Centre, Victory A.R.T. Laboratory Phils. Inc, CHA Fertility Center, United Family Hospital, The New Hope Fertility Center, NOVA IVF Fertility, Baby Joy Fertility and IVF, Fortis La Femme, ART Fertility Clinics, Ferticity Fertility Clinic, Milann Fertility Centre, Fertility First, City Fertility Sydney, Westmead Fertility Centre, Demeter Fertility, Adora Fertility, Rainbow Fertility, Monash IVF Group Limited, Mitra Keluarga Karyasehat Tbk PT, Sarang-i IVF Center, Beyond IVF, Bumrungrad International Hospital, Superior A.R.T, King’s Fertility, Manchester Fertility, St Roch IVF Center, Clinique De La Muette, Institut Marques, Hopital Cochin, iTrust Fertility, Apricity, Agora Clinic, TFP Fertility, Apryl, CCRM Fertility Clinic, ORIGIO, Maven Clinic, Bayonne Centre, Biomedival, Grand Paris Fertility Centre, Ava-Peter Clinic, IVF Russia (The International Centre Of The Reproductive Medicines), Next Generation Clinic, Scandinavia AVA-Peter, Nova Vita Clinic, INVICTA Fertility Clinics, Gyncentrum Fertility Clinic, Md Medical Group, Invo Bioscience, Carolinas Fertility Institute, Newlife Fertility Centre, Dallas Fort Worth Fertility Associates, Overlake Reproductive Health, Fertility Center Of Las Vegas, Weill Cornell Medicine - Center For Reproductive Medicine, UCSF Center For Reproductive Health, Brigham And Women's Hospital Center For Infertility And Reproductive Surgery, Columbia University Fertility Center, Duke Fertility Center, Advanced Fertility Center Of Texas, Cleveland Clinic Fertility Center, NYU Langone Fertility Center, Mayo Clinic Assisted Reproductive Technologies Rochester, Massachusetts General Hospital Fertility Center, IVF Canada, Bio Fertility Center, The Mexican Institute For Higher Reproductive Technology (Inmater), Select IVF, Fertility Patagonia, In Vitro Buenos Aires, Halitus Instituto Medico, Pregna Medicina Reproductiva, IVF Panama Centro De Reproduccion Punta Pacifica, Colombian Center For Fertility, Sterility, Carrot Fertility, Oya Care, Kitazato, Dubai Fertility Center, Fakih IVF Fertility Center, Orchid Fertility, Bourn Hall Fertility Clinic, Alboshra IVF Center, George’s Memorial Medical Centre, Nordica Fertility Centre, The Olive Branch Clinic, St. Ives Specialist Hospital, Bridge Clinic Fertility Centre, Cairo Fertility Centre, Queens Fertility Centre, BPE Partners, Cleopatra Hospitals Group.

Western Europe was the largest region in the fertility services market in 2025. North America was the second largest region in global fertility services market share. The regions covered in the fertility services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the fertility services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the fertility services market by increasing the cost of imported laboratory equipment, cryopreservation systems, and medical consumables. Fertility clinics in Asia-Pacific and Europe are most impacted due to dependence on global medical device suppliers. These higher costs can raise treatment prices and slow service expansion. However, tariffs are driving local equipment manufacturing and service infrastructure, improving long-term service availability.

The fertility services market research report is one of a series of new reports that provides fertility services market statistics, including fertility services industry global market size, regional shares, competitors with a fertility services market share, detailed fertility services market segments, market trends and opportunities, and any further data you may need to thrive in the fertility services industry. This fertility services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Fertility treatment refers to medical procedures designed to enhance the likelihood of conceiving a child. These services are utilized to improve the chances of achieving pregnancy.

The main service types in fertility treatment include fresh non-donor, frozen non-donor, egg and embryo banking, fresh donor, and frozen donor options. In a fresh donor egg IVF cycle, donor eggs are retrieved and immediately fertilized with the male partner’s sperm, and the resulting fresh embryos are transferred to the recipient. Any remaining embryos can be preserved for future frozen embryo transfer procedures. The various treatment methods include assisted reproductive technology (ART), in vitro fertilization, and artificial insemination, and are used by both male and female patients.

The fertility services market includes revenues earned by entities by providing artificial insemination, and intrauterine insemination. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.